SAM
DPLO

Sentinel Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Sentinel Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-802,910
Closed -$16.6M – 167
2017
Q3 		$16.6M Sell
802,910
-67,820
-8% -$1.15M 0.4% 83
2017
Q2 		$12.9M Buy
870,730
+435,520
+100% +$7.26M 0.31% 139
2017
Q1 		$6.94M Buy
+435,210
New +$6.28M 0.16% 162
2016
Q4 		– Sell
-319,884
Closed -$8.96M – 192
2016
Q3 		$8.96M Buy
319,884
+103,035
+48% +$3.46M 0.21% 153
2016
Q2 		$7.59M Buy
216,849
+52,849
+32% +$1.66M 0.18% 163
2016
Q1 		$4.49M Buy
+164,000
New +$4.83M 0.1% 176

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sentinel Asset Management's DPLO Position: Q4 2017 in Review

Sentinel Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 802,910 shares — an estimated $16.6M sold.

Sentinel Asset Management first reported a position in DPLO in Q1 2016 and held it in 6 quarters. The position peaked at $16.6M in Q3 2017. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Sentinel Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Sentinel Asset Management sold 802,910 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $16.6M.
  • Sentinel Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 6 quarters.
  • Sentinel Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $16.6M in Q3 2017.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.